ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 85 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 2.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $574,808 | -48.1% | 388,384 | -43.6% | 0.00% | -100.0% |
| Q2 2023 | $1,107,989 | -46.1% | 688,192 | -2.8% | 0.00% | 0.0% |
| Q1 2023 | $2,053,902 | -9.3% | 708,242 | +2.6% | 0.00% | 0.0% |
| Q4 2022 | $2,264,774 | -13.1% | 690,480 | +0.1% | 0.00% | -50.0% |
| Q3 2022 | $2,607,000 | +618.2% | 689,859 | +1385.3% | 0.00% | – |
| Q2 2022 | $363,000 | -26.2% | 46,445 | -12.2% | 0.00% | – |
| Q1 2022 | $492,000 | -52.6% | 52,918 | -19.6% | 0.00% | – |
| Q4 2021 | $1,038,000 | -78.9% | 65,831 | -76.0% | 0.00% | -100.0% |
| Q3 2021 | $4,912,000 | +14.6% | 274,397 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $4,288,000 | -81.3% | 275,775 | -82.7% | 0.00% | -83.3% |
| Q1 2021 | $22,937,000 | +96.9% | 1,597,227 | +169.2% | 0.01% | +71.4% |
| Q4 2020 | $11,649,000 | +29.1% | 593,380 | -14.8% | 0.01% | +16.7% |
| Q3 2020 | $9,022,000 | -20.9% | 696,177 | -11.1% | 0.01% | -33.3% |
| Q2 2020 | $11,405,000 | +315.5% | 782,784 | +142.6% | 0.01% | +350.0% |
| Q1 2020 | $2,745,000 | -46.5% | 322,671 | +3.6% | 0.00% | -33.3% |
| Q4 2019 | $5,129,000 | +429.3% | 311,476 | +353.1% | 0.00% | +200.0% |
| Q3 2019 | $969,000 | -83.4% | 68,744 | -76.4% | 0.00% | -66.7% |
| Q2 2019 | $5,854,000 | +14.7% | 291,239 | +126.8% | 0.00% | 0.0% |
| Q1 2019 | $5,103,000 | -33.5% | 128,418 | -41.9% | 0.00% | -40.0% |
| Q4 2018 | $7,678,000 | -46.2% | 221,084 | -35.9% | 0.01% | +25.0% |
| Q3 2018 | $14,261,000 | -7.6% | 344,953 | -17.9% | 0.00% | 0.0% |
| Q2 2018 | $15,442,000 | +52.8% | 420,246 | +62.1% | 0.00% | -20.0% |
| Q1 2018 | $10,109,000 | +686.7% | 259,269 | +264.7% | 0.01% | +400.0% |
| Q4 2017 | $1,285,000 | +205.2% | 71,085 | +178.5% | 0.00% | – |
| Q3 2017 | $421,000 | -0.7% | 25,520 | -16.0% | 0.00% | – |
| Q2 2017 | $424,000 | +259.3% | 30,383 | +421.8% | 0.00% | – |
| Q1 2017 | $118,000 | -41.3% | 5,823 | -59.3% | 0.00% | – |
| Q4 2016 | $201,000 | +37.7% | 14,313 | +108.1% | 0.00% | – |
| Q3 2016 | $146,000 | -33.0% | 6,877 | -29.7% | 0.00% | – |
| Q2 2016 | $218,000 | +83.2% | 9,779 | +53.9% | 0.00% | – |
| Q1 2016 | $119,000 | -28.7% | 6,353 | +0.0% | 0.00% | – |
| Q4 2015 | $167,000 | -91.7% | 6,352 | -90.1% | 0.00% | -100.0% |
| Q3 2015 | $2,012,000 | +999.5% | 64,026 | +1738.8% | 0.00% | – |
| Q2 2015 | $183,000 | – | 3,482 | +28916.7% | 0.00% | – |
| Q1 2015 | $0 | – | 12 | +500.0% | 0.00% | – |
| Q4 2014 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |